GENEWIZ Week 2024 marks 25 years of multiomics solutions, featuring workshops, an awards program, and networking opportunities for the research community.
Atossa Therapeutics progresses Phase II preventative breast cancer therapy – Pharmaceutical Technology
Share this article Atossa Therapeutics’ CEO discussed updates for its breast cancer program. Credit: NDAB Creativity via Shutterstock Atossa Therapeutics estimates a Q3 readout of